5839 (74.7%) and 1974 (25.3%) patients had 1 and 2 risk factors respectively
Arch Toxicol 2023;97:1397-412
Both experimental studies and large randomized trials have indicated that the treatment with stable GLP-1 analogues, both before and after onset of ischemic stroke, may be neuroprotective and may reduce the risk of ischemic stroke [12,13,14,15,16,17,18]
But theyre more than buzzwords surrounding popular obesity management drugs (OMDs)
Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
1) were randomized and treated with 150 mg kg 1 5FU, 250 mg kg 1 metformin, a combination of both and/or respective saline vehicles, and tissues were collected 72 h post injection (Fig